Reciprocal Regulation of Plasma Apelin and Vasopressin by Osmotic Stimuli
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Apelin is a neuropeptide that co-localizes with vasopressin (AVP) in magnocellular neurons and is involved in body fluid homeostasis. Osmotic stimuli have opposite effects on the regulation of apelin and AVP secretion in animal models, but whether this is true in humans is unknown. This study investigated the relationship among osmolality, apelin, and AVP in 10 healthy men after infusion of hypertonic saline or loading with water to increase and decrease plasma osmolality, respectively. Increasing plasma osmolality was accompanied by a parallel, linear increase in plasma AVP concentration and by a decrease in plasma apelin concentration. In contrast, decreasing plasma osmolality by water loading reduced plasma AVP concentration and rapidly increased plasma apelin concentration. These findings suggest that regulation of apelin secretion contributes to the maintenance of body fluid homeostasis. The osmotic pressure of body fluids is maintained within a remarkably narrow range in healthy adults. Body fluid homeostasis depends on neuronal pathways bearing very sensitive osmoreceptors,1 located along the lamina terminalis, including the circumventricular organs, such as the subfornical organ and the organum vasculosum of the lamina terminalis as well as the median preoptic nucleus.2 The subfornical organ and organum vasculosum of the lamina terminalis are neuronally interconnected with each other as well as with the median preoptic nucleus and the hypothalamic paraventricular and supraoptic nuclei.3 These neuronal pathways convert small changes in osmolality into a neuronal signal to neurons that influence sensations of thirst and systemic arginine vasopressin (AVP) release,2 thereby adjusting the intake or output of water to counteract changes in solute concentration.4,5 A recently discovered peptide, apelin, may also play a major role in the maintenance of body fluid homeostasis. Apelin, initially isolated from bovine stomach extracts,6 is the endogenous ligand of the human orphan G protein–coupled receptor APJ (putative receptor protein related to the angiotensin receptor AT1).6,7 It is a 36–amino acid peptide (apelin 36) derived from a single 77–amino acid precursor, proapelin.6,8,9 Proapelin has a fully conserved C-terminal 17–amino acid sequence, apelin 17 (K17F), including the pyroglutamyl form of apelin 13 (pE13F). K17F and pE13F both are present in rat brain and plasma,10 and apelin 36 is present in testis and uterus.11 All peptides exhibit a high affinity for the human8,12,13 and the rat apelin receptors.14 Apelin possesses various cardiovascular functions (for reviews,15–17). Apelin and its receptor have been detected in the endothelial cells of large conduit arteries, coronary vessels, and the endocardium of the right atrium.18–20 Apelin injection decreases BP in animals,9,21–23via nitric oxide production.21 Apelin has a positive inotropic effect both on isolated perfused rat hearts ex vivo24 and on normal and postmyocardial infarction rat hearts in vivo.25 Apelin administration in mice reduces left ventricular preload and afterload and increases contractile reserve and cardiac output.26 Finally, apelin-deficient mice develop heart failure with aging.27 Apelin and its receptor both are widely distributed in the brain9,14,28,29 but are particularly abundant in the supraoptic nucleus and paraventricular nucleus, where they co-localize with AVP in magnocellular neurons.10,29–31 Intracerebroventricular injection of K17F inhibits the typical phasic firing pattern of AVP neurons in lactating rats, resulting in decreased systemic AVP release and increased aqueous diuresis.10 Moreover, water deprivation in rats while increasing systemic AVP release and causing depletion of hypothalamic AVP stores decreases plasma apelin concentrations and results in hypothalamic accumulation of the peptide. Thus, the two peptides are conversely regulated to optimize AVP release into the blood circulation and prevent additional water loss through the kidney.10 Whether such opposite regulation of apelin and AVP secretion in response to osmotic stimuli is found in humans remains unknown. The aim of this clinical investigation was to examine the relationship between plasma osmolality, plasma apelin, and plasma AVP in healthy adults in various states of hydration. Hydration was modified by administration of a hypertonic saline infusion and by water loading to increase and decrease plasma osmolality, respectively. RESULTS Characterization of the Molecular Forms of Apelin Present in Human Plasma Apelin immunoreactivity (apelin-IR) was resolved as two major components eluting in fraction 28 and fractions 31 to 32 and a minor component eluting in fraction 40 (Figure 1). Calibration of the C4 column with apelin fragments revealed that the prominent immunoreactive compounds co-eluted with pE13F and K17F, respectively, and that the apelin-IR present in fraction 40 exhibited the same retention time as synthetic apelin 36 (Figure 1). Plas
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia
Schrier, R. W., Gross, P., Gheorghiade, M., Berl, T., Verbalis, J. G., Czerwiec, F. S., & Orlandi, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065181 · Cited by 1,215
Apelin, a Newly Identified Adipokine Up-Regulated by Insulin and Obesity
Boucher, J., Masri, B., Daviaud, D., Gesta, S., Guigné, C., Mazzucotelli, A., Castan-Laurell, I., Tack, I., Knibiehler, B., Carpéné, C., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1427 · Cited by 910
Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding
Heinonen, M. V., Purhonen, A. K., Miettinen, P., Pääkkönen, M., Pirinen, E., Alhava, E., Åkerman, K., & Herzig, K. H. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.05.003 · Cited by 232
Cited by
The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis
O'Carroll, A.-M., Lolait, S. J., Harris, L. E., & Pope, G. R. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0227 · Cited by 344
Targeting the apelin system for the treatment of cardiovascular diseases
Chapman, F. A., Maguire, J. J., Newby, D. E., Davenport, A. P., & Dhaun, N. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad171 · Cited by 104
“165,167,168 Changes in plasma osmolality cause opposing effects on the regulation of vasopressin and apelin release, 16 and the apelin system may therefore represent a target in disorders of water balance such as syndrome of inappropriate antidiuretic hormone.”
BackgroundTaveau, C., Chollet, C., Waeckel, L., Desposito, D., Bichet, D. G., Arthus, M.-F., Magnan, C., Philippe, E., Paradis, V., Foufelle, F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3496-9 · Cited by 86
Zhao, J., Du, S., Yang, J., Lin, J., Tang, C., Du, J., & Jin, H. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.05.039 · Cited by 41
Zhao, J., Tang, C., Jin, H., & Du, J. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.04.032 · Cited by 27
Metadata
- Authors
- Azizi, M., Iturrioz, X., Blanchard, A., Peyrard, S. A. A., De Mota, N., Chartrel, N., Vaudry, H., Corvol, P., & Llorens-Cortes, C.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2008-05
- Volume
- 19
- Issue
- 5
- Pages
- 1015-1024
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2098223295
- Cited by
- 146
- References
- 3
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reciprocal Regulation of Plasma Apelin and Vasopressin by Osmotic Stimuli. https://app.cochat.ai/papers/10.1681/asn.2007070816
- The paper
- Azizi, M., Iturrioz, X., Blanchard, A., Peyrard, S. A. A., De Mota, N., Chartrel, N., Vaudry, H., Corvol, P., & Llorens-Cortes, C. (2008). Reciprocal Regulation of Plasma Apelin and Vasopressin by Osmotic Stimuli. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2007070816
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.